OTCMKTS:AOLS

Aeolus Pharmaceuticals Stock Signals

> Drug Manufacturers - Specialty & Generic

Buy AOLS

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Aeolus Pharmaceuticals, Inc.

General

	Signal Type	Signal Value	Data
	Score	0.000	113 days ( 0 %
	Last Price	$0.0001	0 %
Performance History 7 Days $0.0001 $0.0001 0% 30 Days $0.0001 $0.0001 0% 12 Mos $0.0001 $0.0001 0%

5/18

Active Buy Signals

Premium Feature

Specific Signals

Short Term

Net score: 15.54

Signal Type	Signal Value	Importance	Data
High / Low	N/A	Very Low	$0.0001 - $0.0001
Trend - 3 mos	0 %	High	Width: 0 %
Pred. range - 3 mos	N/A - N/A	Low	-100.00 % - -100.00 %
Volume Direction	Sell	High	Volume: 193 · Direction: 0
Pivot Short	Buy	Very Low	Jun 02, 2026 - 2 days
RSI Short Pivot Signal	Sell	Very Low	Nov 30, -0001 - N/A days
Short MA 3 mos	Sell	Low	Nov 30, -0001 - N/A days
Long MA 3 mos	Sell	Medium	Nov 30, -0001 - N/A days
Short/Long MA 3 mos	Sell	Medium	Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now

Long Term

Net score: 68.5

Signal Type	Signal Value	Importance	Data
Trend - 12 mos	0.00000002408889 %	Very High	Width: 0.00000300066923 %
Pred. range - 12 mos	$0.00009999999704 - $0.0001	High	-0.00000296463112 % - 0.00000003603888 %
Short MA 12 mos	Buy	Very High	Dec 18, 2025 - 114 days
Long MA 12 mos	Buy	Very High	Dec 18, 2025 - 114 days
Short/Long MA 12 mos	Buy	Very High	Jan 15, 2026 - 96 days
Pivot Long	Sell	Low	Jun 02, 2026 - 2 days
RSI Long Pivot Signal	Sell	Low	Jan 09, 2026 - 100 days
Bollinger	Sell	Medium	Nov 30, -0001 - N/A days
MACD	Neutral	High	No Dates Stored For This Signal

Notice: Technical analysis is hidden due to insufficient data.

There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.

If you think this is not correct, please

ABOUT AEOLUS PHARMACEUTICALS, INC.

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and on...

Read Full Profile Here